What is the best way to safeguard poultry health across a wide range of production systems and management teams? That’s a question Rick Phillips, DVM, MAM, director of poultry professional services veterinarians at Boehringer Ingelheim, has explored for more than 25 years while working with live-production teams across the US.
A postbiotic containing the phytogenic substance saponin could assist as a useful tool to help broiler producers reduce the impact of Avian pathogenic Escherichia coli (APEC), which causes colibacillosis.
By Muhammad Ali, DVM
PhD student
Department of Poultry Science, University of Georgia
By Aaron Stephan, PhD
Research and Innovation Director
ONCE by Signify
While most chicks are vaccinated for coccidiosis at the hatchery, it’s the first few weeks in the grower barn that determine coccidia exposure, cycling and eventual immunity.
Coccidiosis vaccination is a critical tool to mitigate economic losses for broiler producers. However, dry litter conditions and low placement densities can complicate successful vaccine replication and subsequent immunizing exposure.
Ultrasonic water meters enabled rapid and early identification of potential problems in cage-free layer houses, including feed shortages and water restrictions, according to research presented at the 2024 IPSF by William Strickland, graduate research assistant, University of Georgia.
Using a dietary supplement containing a blend of Bacillus bacterial strains appears to positively affect the intestinal health and immunity of broiler chicks after a coccidia challenge, according to a Frontiers in Microbiology report.
Past knowledge can provide useful insight to control the latest outbreak of avian metapneumovirus in the US poultry industry, according to two leading experts on the disease.
Despite the industry’s best efforts to control colibacillosis in layers, broilers and breeders, the bacterial disease caused by avian pathogenic Escherichia coli (APEC) continues to challenge producers and researchers.
Ancera has released a new suite of comprehensive monitoring tools to provide allied companies of the poultry industry with real-time, third-party evidence demonstrating product efficacy.
Developing a recombinant vaccine that protects against infectious bursal disease plus two other viral bugs – infectious laryngotracheitis and Marek’s disease – may sound simple on paper. But in the world of vaccine development, 1 + 1 doesn’t necessarily equal 2.
Copyright ©Feeks Media LLC, 2025 | All rights reserved
info@modernpoultry.media
privacy policy | site map
